v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net (loss) income $ (25,091) $ 35,607
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 57,948 58,794
Intangible asset impairment charges 41,242 0
Amortization of debt discount and issuance costs 13,383 12,360
Inventory step-up amortization 0 1,069
Loss on sale of business 13,694 0
Stock-based compensation 25,690 24,621
Deferred income taxes, net (944) (5,784)
Change in fair value of contingent consideration 1,459 (12,087)
Net unrealized foreign exchange loss (gain) (683) (12,443)
Operating lease right of use asset amortization 14,189 13,570
Other adjustments and non-cash items (1,754) 2,532
Changes in operating assets and liabilities, excluding impact of acquisitions:    
Accounts receivable 3,383 (7,302)
Inventories (16,070) (5,346)
Prepaid expenses and other current assets (3,732) (5,494)
Other noncurrent assets 1,916 (1,727)
Accounts payable (523) (5,083)
Accrued liabilities (2,443) 9,629
Operating lease liabilities (18,796) (12,096)
Noncurrent liabilities 1,292 893
Total cash provided by operating activities 104,160 91,713
Cash flows from (for) investing activities    
Acquisitions, net of cash acquired 0 (69,954)
Divestiture proceeds, net of cash divested 3,637 0
Purchases of marketable securities (200,499) 0
Maturities and sales of marketable securities 271,073 0
Additions to capitalized software costs (1,307) (2,055)
Purchases of property, plant and equipment (14,992) (15,366)
Sale of property, plant and equipment 0 42
Other investing activities 0 (2,397)
Total cash provided by (used in) investing activities 57,912 (89,730)
Cash flows from (for) financing activities    
Proceeds from exercise of stock options 15,850 2,142
Payment of tax withholding obligation on vesting of restricted stock (7,765) (7,994)
Payment of earnout consideration (5,225) (9,548)
Total cash provided by (used in) financing activities 2,860 (15,400)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1,943) 4,809
Net increase (decrease) in cash, cash equivalents and restricted cash 162,989 (8,608)
Cash, cash equivalents and restricted cash, beginning of period 566,021 757,355
Cash, cash equivalents and restricted cash, end of period 729,010 748,747
Supplemental disclosure of cash flow information:    
Assets acquired under operating leases 10,634 4,044
Purchases of property, plant and equipment included in accounts payable 2,198 0
Fair value of shares of common stock issued for contingent consideration earnouts 0 7,568
Reconciliation of cash, cash equivalents and restricted cash to condensed consolidated balance sheets    
Cash and cash equivalents 726,960 748,747
Restricted cash included within prepaid expenses and other current assets 2,050 0
Total cash, cash equivalents and restricted cash $ 729,010 $ 748,747